Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW642444 in mild to moderate asthma
NCT00354874Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vilanterol in asthma, sponsored by GSK. Started Jan 2005; status: completed.
02
Drugs
vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00354874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354874.